safety of remdesivir use in patients with impaired kidney function and covid 19 infectio
Not Applicable
- Conditions
- Health Condition 1: N179- Acute kidney failure, unspecifiedHealth Condition 2: N189- Chronic kidney disease, unspecifiedHealth Condition 3: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/12/030046
- Lead Sponsor
- DrMaulin Shah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All covid positive (Rapid antigen test or RT PCR) patients admitted in shree Krishna hospital from March 2020 whose presenting creatinine is more than 1.4 mg/dl in Male or 1.2 mg/dl in Female or who are having oliguria /anuria (urine output less than 0.5 ml/kg/hour in first 24 hours -as per Standard KDIGO criteria) and who also received Remdesivir short or prolonged course during hospital stay will be included.
Exclusion Criteria
Those Covid positive patients with renal dysfunction will be excluded from study if they do not complete the course of remdesevir suggested by clinician.
However, those patients who expired during treatment of remdesivir will be included in study and they will be analyzed separately.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method